Genoa, Italy

Paolo Trifiro′

This inventor holds 1 USPTO granted patent. Top assignee: Nerviano Medical Sciences S.r.l.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paolo Trifiro′. Retrieved from https://idiyas.com/inventor/paolo-trifiro′-bax6dikm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paolo Trifiro′: Innovator in Protein Kinase Inhibitors

Introduction

Paolo Trifiro′ is a notable inventor based in Genoa, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of protein kinase inhibitors. His work is crucial in addressing diseases associated with disregulated protein kinase activity, such as cancer.

Latest Patents

Trifiro′ holds a patent for "3,4-diarylpyrazoles as protein kinase inhibitors." This patent includes 3,4-diarylpyrazole derivatives of formula (I) as defined in the specification, along with pharmaceutically acceptable salts thereof. The patent also outlines the process for their preparation and pharmaceutical compositions that comprise these compounds. The compounds of this invention may be useful in therapy for treating diseases linked to protein kinase activity.

Career Highlights

Paolo Trifiro′ is associated with Nerviano Medical Sciences S.r.l., where he continues to advance his research and development efforts. His work has led to innovative solutions in the pharmaceutical industry, particularly in cancer treatment.

Collaborations

Trifiro′ collaborates with esteemed colleagues, including Gabriella Traquandi and Chiara Marchionni. Their combined expertise enhances the research and development initiatives at Nerviano Medical Sciences S.r.l.

Conclusion

Paolo Trifiro′ is a prominent figure in the field of pharmaceutical innovation, particularly in the development of protein kinase inhibitors. His contributions are vital for advancing therapeutic options for diseases like cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…